+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vabomere 2018 U.S. Promotional Audit Report

  • ID: 4616114
  • Report
  • Region: United States
  • 30 pages
  • MD Details
1 of 3

FEATURED COMPANIES

The 5 Key Questions Addressed by this Report:
  • How many physicians were reached by Vabomere through reportable promotional activity in 2018 and how does this compare to its peer set in the Severe Infection and Urinary Tract Infection markets?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity?
  • How does Melinta's depth of coverage vary within key specialties (e.g., Infectious Disease, Internal Medicine, Podiatry, Family Medicine, General Surgery, Critical Care Medicine, and Pulmonology) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Vabomere throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for Vabomere in 2018?
Data Sources and Methodology:
  • Author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, over 5 years of longitudinal data is available - covering payments to more than 1,000,000 U.S. healthcare professionals.
  • Over 8,800 paid interactions across 4,400 physicians made on behalf of Vabomere were carefully examined to support our analysis. In addition, interaction data from 9 peer products (i.e. Avycaz, Baxdela, Dalvance, Minocin, Orbactiv, Sivextro, Teflaro, Vibativ, and Zerbaxa) was leveraged to provide benchmarking and market insights.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

Overview:
  • Introduction
  • Sunshine Act and Open Payments Data
  • Transfer of Value
  • Author's Platform
Vabomere - Peer Set:
  • Vabomere Peer Set Selection
Vabomere - Promotional Benchmarking:
  • Chart 1 Total Number of Physicians Reached by Specialty Type
  • Chart 2 Distribution of Physicians Reached by Specialty Type
  • Chart 3 Total Number of Payments by Type
  • Chart 4 Distribution of Payments by Type
  • Chart 5 Total Number of Payments / Week
  • Chart 6 Payment Value by Type
Vabomere - Physician Coverage by Geography:
  • Chart 7 Infectious Disease
  • Chart 8 Internal Medicine
  • Chart 9 Podiatry
  • Chart 10 Family Medicine
  • Chart 11 General Surgery
  • Chart 12 Critical Care Medicine
  • Chart 13 Pulmonology
Vabomere - Meal Frequency:
  • Chart 14 Infectious Disease
  • Chart 15 Internal Medicine
  • Chart 16 Podiatry
  • Chart 17 Family Medicine
  • Chart 18 General Surgery
  • Chart 19 Critical Care Medicine
  • Chart 20 Pulmonology
Vabomere - Most Engaged Physicians:
  • Table 1: Top Physicians (By Total Number of Meals) in 2018
  • Table 2: Top Speakers (By Total Number of Speaking Events) in 2018
About:
  • Background
  • Service Lines
  • Contact
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Melinta
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4616114
Adroll
adroll